Company Filing History:
Years Active: 2025
Title: Srisathya Srinivasan: Innovator in Immunotherapy
Introduction
Srisathya Srinivasan is a notable inventor based in Mumbai, India. He has made significant contributions to the field of immunotherapy through his innovative research and development. His work focuses on advancing treatments for diseases associated with the expression of the Cluster of Differentiation 19 protein (CD19).
Latest Patents
Srinivasan holds a patent for a "Humanized anti-CD19 chimeric antigen receptor, its nucleic acid sequence and its preparation." This invention relates to a novel humanized anti-CD19 chimeric antigen receptor that contains an optimized anti-CD19 binding domain. It is effective in treating diseases linked to CD19 expression. The patent also encompasses a nucleic acid molecule encoding the humanized CAR, a process for its preparation, and compositions containing the CAR. Additionally, it includes vectors with the polynucleotide encoding the CAR and cells expressing the CAR on their surface, particularly for use in immunotherapy. He has 1 patent to his name.
Career Highlights
Srinivasan is affiliated with the Indian Institute of Technology Bombay, where he conducts his research. His work has garnered attention for its potential impact on immunotherapy and cancer treatment.
Collaborations
Srinivasan collaborates with notable colleagues, including Rahul Purwar and Alka Dwivedi, to further his research initiatives.
Conclusion
Srisathya Srinivasan is a pioneering inventor whose work in immunotherapy is paving the way for innovative treatments. His contributions are vital in the ongoing fight against diseases associated with CD19 expression.